|
NF2 Natural History Consortium Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about NF2 Natural History Consortium conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. NF2 Natural History Consortium Clinical research trials and NF2 Natural History Consortium healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as NF2 Natural History Consortium. NF2 Natural History Consortium Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a NF2 Natural History Consortium clinical trial. Subjects frequently obtain the most expert healthcare possible for their NF2 Natural History Consortium condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > NF2 Natural History Consortium  NF2 Natural History Consortium
NF2 Natural History Consortium
For Condition: Meningioma,Schwannoma, Vestibular,Neurofibromatosis 2
Status: Recruiting
Sponsor(s): House Ear Institute ,
Synopsis: OBJECTIVES: I. Define the growth rates and clinical course of NF2-related tumors in patients with neurofibromatosis type 2. Associate growth rate with physical function.
Details: PROTOCOL OUTLINE: Data on the clinical course and growth rate of NF2-related tumors in patients with neurofibromatosis 2. Patients are evaluated each year on a cranial and a spinal MRI, eye tests, hearing tests, quality of life, neurological tests, and physical functioning.
Eligibility:
Study Type: Observational, Natural History, Longitudinal
Minimum Age/Maximum Age: 5 Years/
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Diagnosed with neurofibromatosis 2 on or after 01/01/93 - Must meet one of the following conditions: Bilateral vestibular schwannoma OR Family history of neurofibromatosis 2 (first degree family relative) AND Unilateral vestibular schwannoma at under 30 years OR Any 2 of the following: Meningioma Glioma Schwannoma Juvenile posterior subcapsular lenticular opacity/juvenile cortical cataract - No plans to treat vestibular schwannoma in next 12 months --Prior/Concurrent Therapy-- - Not specified --Patient Characteristics-- - Age: 5 and over
Total Enrollment: 100
Location and Contact Information:
Overall Study Official:
WilliamSlattery, Study Chair, House Ear Institute
University of Texas Health Science Center - Houston *Recruiting*
Houston, Texas, 77225
United States
Recruiting Joseph Chang 713-792-4875
Ohio State University *Recruiting*
Columbus, Ohio, 43210
United States
Recruiting D. Welling 614-292-2424
House Ear Institute *Recruiting*
Los Angeles, California, 90057-9927
United States
Recruiting William Slattery 213-483-9930
Klinikum Nord Ochsenzoll *Recruiting*
Hamburg, , 22419
Germany
Recruiting Victor Mautner 49-40-5271-2872
Royal Victorian Eye and Ear Infirmary *Recruiting*
Melbourne, ,
Australia
Recruiting Robert Briggs 03 9929 8666
Massachusetts General Hospital *Recruiting*
Boston, Massachusetts, 02114-2617
United States
Recruiting Mia MacCollin 617-726-5724
Mount Sinai Medical Center, NY *Recruiting*
New York City, New York, 10029
United States
Recruiting William Carroll 212-241-4142
Additional Information:
Study ID Numbers: 199/14226; HEI-NF2,HEI-DAMD17-01-1-0710
Study Start Date: January 2002
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004483
Other Neurofibromatosis 2 Studies:
1. NF2 Natural History Consortium
Related Studies:
Other Neurofibromatosis 2 Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
NF2 Natural History Consortium
|
|
|
|
|
|
|
|
